News About: Pharm. Industry
Pharmas extend rebate control to client distributors
While the pharmaceutical industry has recently had rebate issues once again, individual pharmaceutical companies are tightening their own rules to eradicate rebates.
They have only performed a program to eradicate re...
TissueGene receives a grand for ‘Invossa’ development from U.S. Maryland
TissueGene(CEO Bum-Seop Lee/Woo-Seok Lee) Co-CEO Woo-Seok Lee participated in a reception at Habib House, the U.S. Ambassador to South Korea’s residence in Seoul, hosted by officials the Maryland Department of Commerc...
Dongwha Pharm-MSD Korea signs license agreement of antidepressant ‘Remeron’
Dongwha Pharm(CEO Ji-Hoon Sohn) signed a MSD’s exclusive sale and supply agreement of Remeron(generic name: mirtazapine), a MSD’s antidepressant, in Korea on the 8th of September.
Remeron, a MSD’s NaSSA(antidepressan...
Seoul Western DPO considers to start clinic S’s rebate investigation
The pharmaceutical field is getting nervous as the Seoul Western District Prosecutor’s Office(Seoul Western DPO), which has been quiet over pharmaceutical companies’ rebates, have shown movements to start a rebate inv...
Celltrion’s biosimilar ‘Herzuma’ proven in equivalence of efficacy with original
At the European Society for Medical Oncology(ESMO) symposium on the 9th(local time) in Madrid, Spain, Celltrion announced additional clinical trial results of 1-year safety of Herzuma(development name: CT-P6), an anti...
The amount of listed pharmas’ foreigner-owned stocks appraised is KRW 3.8 trillion
The amount of listed pharmaceutical companies’ stocks owned by foreign investors was appraised KRW 3.8 billion.
Yakup Shinmoon(www.yakup.com) analyzed the KOSPI and KOSDAQ listed pharmaceutical companies’ ratio of fo...
Boryung Pharm successfully hold Dukarb’s 1st anniversary symposium
Boryung Pharm(CEO Tae-Hong Choi) held a special symposium at Paradise City Hotel & Resort Incheon between the 9th and 10th to celebrate the Dukarb’s 1st release anniversary. Dukarb is a Kanarb/amlodipine combination m...
Daehwa Pharmaceutical signs Chinese technology transfer agreement of ‘Liporaxel Soln’ for USD 25 million
Daehwa Pharmaceutical announced on the 6th that the company signed a technology transfer agreement of the world’s first approved oral paclitaxel anticancer drug(Korean product name: Liporaxel Soln) for USD 25 million ...
Dong Wha Pharm-GSK Consumer’s sale and supply agreement of OTC medicines
Dong Wha Pharm(CEO Ji-Hoon Sohn) held a sale and supply agreement ceremony of total 10 OTC medicines including the entire 7 OTC medicines owned by GSK Consumer Healthcare Korea and GSK Consumer Healthcare(GSK CH) at G...
3 listed pharmas showing danger signal in financial structure
Although most listed pharmaceutical companies were evaluated to have a sound financial structure, some pharmaceutical companies were criticized to show a danger signal on soundness of the financial structure.
Yakup S...
